C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/435 (2006.01) A61K 31/535 (2006.01) C07D 498/04 (2006.01)
Patent
CA 2174850
Compounds represented by general formula (I) having affinity for the 5-HTIA receptor are disclosed as useful in treating diseases of the central nervous system.
L'invention décrit des composés représentés par la formule générale (I), qui présentent une affinité pour le récepteur de la 5-HT1A. Ces composés sont utiles pour le traitement des maladies du système nerveux central.
Baxter Ellen W.
Reitz Allen B.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Ortho Pharmaceutical Corporation
LandOfFree
Tricyclic compounds having affinity for the 5-ht1a receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic compounds having affinity for the 5-ht1a receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds having affinity for the 5-ht1a receptor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1928164